Clinical cases of brain cancer

Case 1: Pathology Malignant Ependimome

Age: 5

Reason why consults:

Intracranial high pressure secondary to water in the brain (hydrocephalus) and a expansive mass located at the right with extension to the cuadrigeminal region.

Personal history:

Nothing relevant.

Family history:

Nothing relevant.

Illness’ evolution:

Full dose of radiotherapy and chimiotherapy. A tomography done in October 2002 shows a good evolution of the neoplasi injury ando f the water in the brain. December2002,neurologic progressive damage.16th december,2002 ner surgery and total removal of the injury.

Starts with the treatment with our medicine: 10 drops 4 times a day. One month later we increase the dose to 20 drops. At the same time a vegetarian diet was taking place.
3rd March,200 the child is in great condition, energy and vitality intact. Very good clinic and neurologic condition. In the present, excellent health. Symptoms gone. Continues with supervisión and a maintainance dose of the medicine.

Conclusions:

5 year old patient coming from Paraguay. Begins the treatment with 10 drops 4 times a day and the next month it was increased to 20 drops. Nowadays the child is in great condition, without symptoms. A base dose is kept.

Case 2: Malignant Ependimome

Age:8 years and a half

Reason why consults:

Noviembre 1995. a tumor was detected in the right hemisphere.

Personal history:

Nothing relevant.

Family history:

Nothing relevant.

History of the illness:

Treatment: Neurosurgery.

Illness’ evolution:

Starts on April 25th,2002 with 3 takes a day with 25 drops each that were increased to 4 times a day in July, 2002.
17/08/2002: the tumor shows a slight improvement. There is a good tolerante to the medicine. Veryo good mood, good vitality and normal activity. By the end of October 2003 is finishing the 90 days period with 25 drops 4 times a day.

Conclusions:

It is evident that Basquade’s action has gone through the hematoencephalic barrier and actino in the ways it usually does, mainly in the central nervous system has given good results.
Undoubtedly, Basqüadé® has a great action in the central nervous system that puts it among those medicines which should be considered before starting a treatment.

Case 3: Oligodendrogliome-Gliobastome pathology

Age: 74

Reason why consults:

Brain tumor

Personal history:

Nothing relevant.

Family history:

Nothing relevant.

History of the present illness:

28/09/1999 a biopsy shows a primary mixed brain malignant neoplasia ,oligodendrogliome-gliobastome.

Illness’ evolution:

Starts taking Basqüadé® drops: 40 drops 6 times a day in August, 2000.

We must highlight that the patient received in all this period Basqüadé® drops as medicine, being (as the imagenology studies show) stable since two years and a half ago only using this medicine.
Conclusions:

74 years old patient with a malignant neoplasia in the brain. In the year 200, the patient starts taking our medicine keeping the imagenology unchanged and with a tendency to reduction. Basqüadé® acted evidently going through the hematoencephalic barrier as we suggested in the antitumoral action of Basqüadé® in the central nervous system.

Today, with our acquired experience and the results obtained we firmly think that Basqüadé® has a deserved place in the treatment of tumors in the central nervous system. We must highlight that there wasn’t intracranial high pressure symptom and this would be linked to the effect of mass removed by surgery but also to the anti-inflammatory and stabilizing effect of Basqüadé® .

We are proud of this case. Our medicine has taken a patient of difficult prognosis to a healthy condition. Basqüadé® is a medicine of proved efficiency, even in severe affections.

Return